Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease
Clinical trial NCT00781430 · COMPLETED
Trial details
- NCT number
- NCT00781430
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-02-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.